Skip Navigation

OU College of Medicine Professor Earns Prestigious Pancreatology Award

NEWS
Min Li, Ph.D..
Min Li, Ph.D.

OU College of Medicine Professor Earns Prestigious Pancreatology Award


By

April Wilkerson
april-j-wilkerson@ouhsc.edu

Date

Nov. 22, 2024

OKLAHOMA CITY – Min Li, Ph.D., a George Lynn Cross Professor of Medicine, Surgery and Cell Biology at the University of Oklahoma College of Medicine and Associate Director for Global Oncology at OU Health Stephenson Cancer Center, will receive the 2024 Palade Prize from the International Association of Pancreatology.

The Palade Prize, the IAP’s most distinguished award for research excellence, recognizes Li’s contributions to the field of pancreatology, which is dedicated to discovering new methods of identifying, diagnosing and treating diseases of the pancreas such as pancreatic cancer. The award is named after George E. Palade, who won the Nobel Prize in 1974 for his pioneering work involving a specialized pancreatic cell type. Li will receive the prize during the IAP annual meeting Dec. 9-12, and he will give a lecture on cancer cachexia and metabolic reprogramming.

Li has been continuously funded by the National Cancer Institute, a component of the National Institutes of Health, for the past 15 years, including three active R01 grants. His contributions to science focus on three areas:

  • Development of a combination therapy for pancreatic cancer using a novel surgical mouse model. As part of this work, his laboratory was the first to discover the role of a zinc transporter called ZIP4 in both pancreatic cancer and cachexia, a muscle-wasting condition that often occurs in tandem with pancreatic cancer.
  • Metabolic reprogramming and muscle wasting in pancreatic cancer. In this area, Li searches for a method of controlling the rapid weight loss of cachexia, which has no treatment. He is currently focused on the role of several enzymes and growth factors in the progression of cachexia.
  • Immunotherapy of pancreatic cancer. Because most immunotherapy drugs alone are not effective against pancreatic cancer, Li’s team developed a phototherapy/immunotherapy combination treatment that has been highly effective in mice with metastatic pancreatic cancer.

Li has published 216 articles in high-impact peer-reviewed journals and has given presentations on his research around the world. He has also mentored more than 30 graduate students and postdoctoral fellows, who have gone on to research careers in academia and industry, as well as junior faculty members who are beginning their careers.

Li is immediate past president of the American Pancreatic Association and is a standing member of the NIH Developmental Therapeutics study section and an ad hoc member of many other NIH study sections. He is editor-in-chief for the journal Cancer Letters and is an editorial board member for several other prestigious journals, including Clinical Cancer Research and BMC Medicine. He is also a member of the American Association for Cancer Research and the Association for Academic Surgeons.

He holds several other titles at OU Health Sciences, including Assistant Dean for International Research Collaboration in the OU College of Medicine; Vice Chairman for Research in the Department of Medicine and Department of Surgery, OU College of Medicine; and co-leader of the Cancer Biology Program at OU Health Stephenson Cancer Center. He also holds the Virginia Kerley Cade Endowed Chair in Cancer Treatment.

About the University of Oklahoma

Founded in 1890, the University of Oklahoma is a public research university with campuses in Norman, Oklahoma City and Tulsa. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. In Oklahoma City, OU Health Sciences is one of the nation’s few academic health centers with seven health profession colleges located on the same campus. OU Health Sciences serves approximately 4,000 students in more than 70 undergraduate and graduate degree programs spanning Oklahoma City and Tulsa and is the leading research institution in Oklahoma. For more information about OU Health Sciences, visit www.ouhsc.edu.


Recent News

Impact
October 21, 2026

Alumni family creates lasting impact with athletics and business gifts

The University of Oklahoma has received a transformative gift from Jon and Shannon McCartney, which will name the McCartney Family Tunnel of Champions, the McCartney Family Gate of the Gaylord Family - Oklahoma Memorial Stadium and the McCartney Family Grand Lecture Hall in the Michael F. Price College of Business. The gift will also support the Inspiring Champions and the Athletic Director’s Discretionary Fund, in addition to establishing the McCartney DFW Career Trek program at Price College.


Campus & Community
October 21, 2026

OU Max Westheimer Airport celebrates opening of new air traffic control tower

The University of Oklahoma today celebrated the opening of a new air traffic control tower at the OU Max Westheimer Airport. Standing 106 feet tall, more than double the current 52-foot facility, the new tower will modernize air traffic control operations and improve safety for pilots and students operating in the airspace.


Campus & Community
October 20, 2026

Understanding the Barriers to Better Health

Do I buy groceries or pay the electric bill? Should I pawn some of my belongings to afford my prescription? My child is sick, so I will have to miss work to take care of him. Those are just a few of the difficult choices that OU-Tulsa health professional students confronted during the Community Access to Resources Experience. The role-playing activity challenged students to navigate the financial, family and other pressures that can affect a person’s health and ability to follow medical advice. Held annually during the SCM Institute orientation week, the experience is designed to generate understanding and build empathy.